Author: Jhaveri, Ravi
Title: Screening for Hepatitis C Virus: How Universal Is Universal? Cord-id: d1ylvt5w Document date: 2020_7_23
ID: d1ylvt5w
Snippet: In March and April of 2020, public health authorities issued major updates to screening recommendations for hepatitis C virus infection. With the rise in cases driven by injection drug use coupled with access to highly effective therapies promising a cure, all adults aged ≥18 years should receive one-time hepatitis C virus antibody screening in any health care setting. Although the recommendation is dubbed “universal,†this commentary reviews the details of the recommendations and discusse
Document: In March and April of 2020, public health authorities issued major updates to screening recommendations for hepatitis C virus infection. With the rise in cases driven by injection drug use coupled with access to highly effective therapies promising a cure, all adults aged ≥18 years should receive one-time hepatitis C virus antibody screening in any health care setting. Although the recommendation is dubbed “universal,†this commentary reviews the details of the recommendations and discusses the high-risk populations not entirely captured with these changes.
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date